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 Abstract  Mammalian sperm acquire fertilizing capacity during epididymal transit. 
During this process, the expression of protein disulfi de isomerase-P5 (PDI-P5, P5) 
decreases. Almost all members of the PDI family accelerate the formation, reduc-
tion, and isomerization of disulfi de bonds, whereas boar P5, which is composed of 
two active thioredoxin domains,  a and  a′ , and an inactive  b domain, inhibits the 
oxidative refolding of reduced and denatured lysozyme due to nonproductively 
folded lysozyme resulting from intermolecular isomerization. We investigated the 
reductive activities of cysteine mutants of boar P5 and of the  a and  a′b domains, 
using an insulin turbidity assay, and their ability to inhibit the oxidative refolding of 
reduced and denatured lysozyme. We also analyzed refolded products by Western 
blotting. The reductive activities of the C-terminal variants, C171A, C174A, and 
C171/174A, were lower than those of the N-terminal variants C36A, C39A, C36/39A, 
and  a′b . The inhibitory activities of N- and C-terminal cysteine mutants were ~60 % 
and ~75 %, respectively, whereas the inhibitory activities of C36/39A and of  a′b 
were ~60 % and 30 %, respectively. The properties of a mixture of  a and  a′b were 
similar to those of  a′b alone. These results suggested that two active domains of P5 
cooperatively inhibited refolding by intermolecular isomerization and that this effect 
was increased when the  a and  a′b domains were linked. The fi ndings were supported 
by Western blotting analysis of the refolded products. These results provide new 
insight into the molecular mechanism by which P5 inhibits protein refolding. 
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9.1  Introduction 
 Caput epididymal sperm released from the testes are biologically incompetent, 
acquiring functionality during transit from the epididymal caput to the cauda via the 
corpus. Ejaculated sperm are able to move vigorously and participate in the com-
plex cascades of interactions that culminate in fertilization of the oocyte 
(Yanagimachi et al.  1994 ). Various kinds of studies on epididymal sperm maturation 
have been reported (McLaughlin et al.  1997 ; Frayne et al.  1998 ; Zhu et al.  2001 ; 
Saxena et al.  2002 ; Baker et al.  2005 ,  2012 ; Ellerman et al.  2006 ; Toshimori et al. 
 2006 ; Inoue et al.  2008 ; Ijiri et al.  2011 ). Protein disulfi de isomerase-P5 (PDI-P5, 
P5) has been reported present in mouse sperm membrane fraction (Stein et al.  2006 ) 
and to be involved in asymmetrical organogenesis in zebrafi sh (Hoshijima et al. 
 2002 ), in regulating human platelet function (Jordan et al.  2005 ), and in promoting 
the ability of human tumors to evade the immune system (Kaiser et al.  2007 ; 
Gumireddy et al.  2007 ). We have reported that boar P5 is downregulated during 
transit from the epididymal corpus to the cauda and inhibits  oxidative refolding of 
reduced and denatured lysozyme (Akama et al.  2010 ). To date, however, the mecha-
nism by which P5 inhibits protein refolding has not been elucidated. 
 P5 is composed of two active thioredoxin domains,  a and  a′ , and an inactive 
 b domain, with each active thioredoxin domain containing an active CGHC site. 
We investigated the mechanism by which P5 inhibits protein refolding by assaying 
the inhibitory activities of highly purifi ed domain-deleted or cysteine variants of P5. 
Our results suggest that the  a domain inhibits refolding by promoting the intermo-
lecular isomerization of lysozyme with the  a′ domain, with the  a-a′b attachment 
essential for complete inhibition. 
9.2  Materials and Methods 
9.2.1  Expression and Purifi cation of PDI-P5 Variants 
 The cDNAs corresponding to P5 deletion variants, the  a and  a′b fragments, were 
amplifi ed by polymerase chain reaction (PCR) and inserted into the expression 
 vector pET30a(+) (Novagen). The cysteine mutants of P5 cDNA were generated by 
amplifi cation of wild-type P5 cDNA cloned into pET30a(+) vector using pfu poly-
merase (Promega). The domain structure of P5 and its variants are shown in Fig.  9.1 . 
Expression and purifi cation of pET-PDI-P5 variants were performed as described 
(Akama et al.  2010 ), with ammonium sulfate precipitation and hydrophobic chro-
matography on phenyl-Sepharose (CL-4B) (GE Healthcare Bio-Science) performed 
before affi nity chromatography.
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9.2.2  Insulin Turbidity and Lysozyme Refolding Assays 
 Insulin turbidity (Holmgren  1979 ) and lysozme refolding (Puig and Gilbert  1994 ) 
assays were performed as described. 
9.2.3  Western Blotting 
 Reaction products of lysozyme refolding assay were Western blotted as described 
(Akama et al.  2010 ). 
9.3  Results 
9.3.1  Reductive Activity of  a′ Domain 
 Purifi ed recombinant mature P5 showed thiol-dependent reductase activity, catalyzing 
the reduction of insulin disulfi des with DTT as previously reported (Akama et al. 
 2010 ). All cysteine-to-alanine mutations decreased the reductive activity of P5. 
 Fig. 9.1  Domain structure of boar P5 and its variants.  (a) Domain organization of boar P5.  (b) P5 
variants: active domains are shown in light brown and the inactive domain in  light gray . Replacement 
of cysteines by alanines is shown in  boldface 
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C-terminal mutants (C171A, C174A, and C171/174A) had about ~50 % of the 
activity of wild type, whereas N-terminal mutants (C36A, C39A, C36/39A and  a′b ) 
had about ~75 % of the activity, suggesting that the disulfi de reducing activity of the 
 a′ domain was greater than that of the other domains. The quadruple mutant 
C36/39/171/174A, in which all four active cysteines were mutated to alanine, had 
no reducing activity, indicating that cysteines located in the inactive thioredoxin 
domain,  b , were not involved in disulfi de reduction. 
9.3.2  Chaperone Activities of the P5 Mutants 
 Reduced and denatured lysozyme is commonly used as a substrate to determine 
whether PDIs have chaperone activity and promote oxidative refolding in vitro. Most 
PDI family members possess chaperone activity, catalyzing the formation and rear-
rangement of disulfi de bonds during the correct folding of nascent proteins. We have 
found, however, that P5 possesses anti-chaperone activity, inhibiting the oxidative 
refolding of the denatured lysozyme (Akama et al.  2010 ). Western blot analysis has 
suggested that the anti-chaperone activity of P5 is the result of its intermolecular 
isomerization with lysozyme, yielding lysozyme aggregates (Akama et al.  2010 ). 
 To clarify this mechanism, we compared the ability of P5 and P5 mutants to 
inhibit oxidative refolding. The  a domain enhanced lysozyme refolding, behaving 
like thioredoxin alone, whereas the  a′b fragment without the N-terminal  a domain 
inhibited folding ~30 % compared with the wild type (100 %). The inhibitory activ-
ity of equal concentrations of the  a and  a′b fragments was similar to that of  a′b 
alone, suggesting that the enhancement of refolding by the  a domain did not occur 
when  a′b was present. The double N-terminal mutant C36/39A had greater inhibi-
tory activity (60 %) than  a′b . These results suggested that the presence of the 
 a domain enhanced the intermolecular isomerization of P5 with denatured lysozyme, 
and that the covalent bonding of  a to  a′b was essential for complete inhibition. The other 
N-terminal active domain mutants (C36A, C39A) had ~60 % and the C-terminal 
active domain mutants (C171A, C174A and C171/174A) had ~75 % of the activity 
of the wild type, indicating that the  a domain inhibited refolding when combined 
with the  a′ domain. 
9.3.3  Detection of Lysozyme Aggregates by Western Blotting 
 Our previous study has indicated that the P5 inhibition of lysozyme refolding is caused 
by lysozyme aggregates resulting from intermolecular isomerization. Using Western 
blotting, we found that the quantity of lysozyme aggregates was reduced when refold-
ing was catalyzed by C36A and C171A, compared with native P5 (Fig.  9.2 ). 
Spontaneous crosslinking of reduced and denatured lysozyme alone was observed in 
refolding buffer (Fig.  9.2 ), explaining why its refolding rate was no higher than 40 %. 
M. Miyakawa et al.
109
In the presence of native P5, lysozyme aggregates were detected in the high molecular 
region, while lysozyme intermediates were not, similar to our earlier fi ndings (Akama 
et al.  2010 ). In the presence of C36A or C171A, lysozyme intermediates had higher 
molecular weights than those of lysozyme alone, with the amounts of aggregates 
being smaller than for P5. No aggregates were observed in the presence of  a′b , but the 
sizes of the intermediates were smaller than those observed with the cysteine mutants. 
These results further indicated that the  a and  a′ domains cooperatively contributed to 
the production of lysozyme aggregates and that the  a domain accelerated the aggre-
gate production.
9.4  Discussion 
9.4.1  Collaborative Isomerization by Two Active Domains 
 The results of the lysozyme refolding assay showed that N-terminal active cysteines 
contribute more to the inhibition of refolding than C-terminal active cysteines, simi-
lar to fi ndings with rat and human P5 (Kramer et al.  2001 ; Kikuchi et al.  2002 ). 
 Fig. 9.2  Western blotting of refolded products of lysozyme. * 1 , intermolecular crosslinked 
aggregates. * 2 , crosslinked intermediates (highly crosslinked, lanes 7 and 8). *3, intermediates of 
lysozyme produced during spontaneous refolding. *4l, lysozyme monomers.  P5s , P5 and its 
variants;  nP5 , native P5;  R , reduced;  NR , nonreduced. P5 concentration, 0.6 μM 
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Using human P5 variants, a single active domain, particularly the  a domain, has 
been shown suffi cient for isomerase activity (Kikuchi et al.  2002 ). When both cys-
teines in either the  a or  a′ domain are replaced with serine, the isomerase activities 
of C36/39S and C171/174S, using insulin as a substrate, are 50 % and 75 %, respec-
tively, relative to the wild type, suggesting that the  a domain can compensate for the 
replacement of cysteines in the  a′ domain. However, a study of yeast PDI has shown 
that the isomerase activity of mutants, in which cysteines residues were replaced 
with alanine, is less than that of the serine mutants, a fi nding thought to be the result 
of the reducing activity remaining in the hydroxyl group of serine (Tian et al.  2006 ). 
 Using a lysozyme refolding assay, we found that the inhibitory activity of the 
N-terminal mutants (C36A, C39A, and C36/39A) was ~60 % of that of the wild 
type, whereas the inhibitory activity of the C-terminal mutants (C171A, C174A, 
and C171/174A) was ~75 %, indicating that both active domains collaborate in 
intermolecular isomerization. Western blotting showed that comparable amounts of 
lysozyme aggregates were present in the presence of C36A or C171A, indicating 
that the  a and  a′ domains cooperatively inhibited refolding. The relatively stronger 
reducing activity of the  a′ relative to the  a domain observed in the insulin turbidity 
assay also suggested collaborative isomerization. The refolding inhibitory activity 
of both  a′b and the mixture of  a and  a′b was 30 % of that of the wild type, suggest-
ing that a covalent bond between the two was essential for complete inhibition. This 
fi nding was supported by our Western blotting results, with  a′b alone showing lyso-
zyme intermediates but no aggregates. The collaborative inhibition by the  a and  a′ 
domains suggests that they have comparable access to substrates, although these 
domains are adjacent to each other, possibly because the amino acid chain is rela-
tively long (36 residues) between these domains, enabling the  a domain to move 
widely. The more effi cient inhibition by C36/39A, in which both cysteines in the 
 a domain were mutated to inactive alanine, than by  a′b , which lacked an  a domain, 
suggests that the mobile  a domain holds and stabilizes large lysozyme aggregates. 
9.4.2  Importance of Thioredoxin Domain Order 
 Evolution has given rise to the PDI family of proteins, with 1–6 thioredoxin 
domain(s). The ancestral PDIs may have been characterized by active domains 
packed together, with these domains structurally separated in descendant PDIs 
(Pedone et al.  2010 ). Protein disulfi de oxidoreductases (PDOs), composed of only 
two thioredoxin domains, can be classifi ed as ancestral types. P5 may also be classi-
fi ed as an ancestral PDI because it contains three thioredoxin domains, in the order 
 a ,  a′ , and  b , similar to PDOs. The domain structure of P5, consisting of two contigu-
ous active domains and a third inactive domain, may be responsible for its potent 
isomerization activity and unique function; this in turn may be the result of the 
 nonspecialized roles of both the  a and  a′ domains. Rather, they cooperatively isomerize 
disulfi des. The downregulation of P5 from the epididymal corpus to the cauda sug-
gests that its potent isomerization activity may be involved in sperm maturation. 
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9.5  Conclusion 
 We investigated the properties of domain-deleted and cysteine variants of P5 having 
an active  a and  a′ domain and an inactive  b domain. The reductive activities of 
C171A, C174A, and C171/174A ( a′ domain variants) were ~50 % of the wild type, 
whereas those of C36A, C39A, C36/39A ( a domain variants), and  a′b were ~75 %. 
The inhibitory activities of lysozyme refolding of  a and  a′ domain variants were 
~60 % and ~75 % of wild type, respectively, whereas the inhibitory activity of a 
mixture of  a and  a′b was 30 % as well as that of  a′b . Together with the results of 
Western blotting, these fi ndings suggested that two active domains of P5 coopera-
tively inhibited lysozyme refolding by intermolecular isomerization, and that the 
isomerase activity was enhanced by  a domain and the covalent bond between  a and 
 a′b was essential for the “potent” isomerase activity. Our fi nding on its isomerization 
mechanism may contribute for further understanding of molecular basis of sperm 
maturation, asymmetrical organogenesis, and tumor immune evasion. 
 Open Access: This article is distributed under the terms of the Creative Commons Attribution 
Noncommercial License which permits any noncommercial use, distribution, and reproduction in 
any medium, provided the original author(s) and source are credited. 
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